M-Xylene

M-Xylene

SCHEMBL18496754

C=C(C)C(=O)O.Cc1cccc(C)c1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.55
▸ LMNA P02545 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ PARP1 P09874 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CTBP2 P56545 1/20 0.44
▸ HDAC8 Q9BY41 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ POLB P06746 2/20 0.43
▸ GAA P10253 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ KCNK3 O14649 2/20 0.41
▸ KCNK9 Q9NPC2 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
M-Xylene SCHEMBL27141133 1.00 ACHE (0.55) ACHELMNAHSD17B10PARP1SMN1; SMN2
Methacrylic Acid SCHEMBL29876675 0.90 ACHE (0.44) ACHELMNAHSD17B10PARP1SMN1; SMN2
M-Xylene SCHEMBL28071717 0.86 ACHE (0.55) ACHELMNAHSD17B10PARP1SMN1; SMN2
Toluene SCHEMBL1692174 0.86 LMNA (0.55) ACHELMNAHSD17B10SMN1; SMN2POLB
Toluene SCHEMBL10539493 0.86 LMNA (0.55) ACHELMNAHSD17B10SMN1; SMN2POLB
M-Xylene SCHEMBL31229728 0.85 ACHE (0.67) ACHELMNAHSD17B10PARP1SMN1; SMN2
Methacrylic Acid SCHEMBL28652025 0.85 TPMT (0.52) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
M-Xylene SCHEMBL28689368 0.84 PARP1 (0.55) ACHELMNAHSD17B10PARP1SMN1; SMN2
M-Xylene SCHEMBL11703686 0.83 ACHE (0.63) ACHELMNAHSD17B10PARP1SMN1; SMN2
M-Xylene SCHEMBL27785615 0.83 ACHE (0.63) ACHELMNAHSD17B10PARP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115322100-A Delta, epsilon-alkenyl ketone compound and preparation method and application thereof 南京工业大学 2022-11-11 — — CN claimed
CN-113200856-A Trifluoromethyl propylene compound and preparation method and application thereof 南京工业大学 2021-08-03 — — CN claimed
US-20260031392-A1 LITHIUM METAL BATTERY AND METHOD FOR MANUFACTURING LITHIUM METAL BATTERY SAMSUNG SDI CO LTD (KR) 2026-01-29 — — US disclosed
EP-4579846-A1 LITHIUM METAL BATTERY AND METHOD FOR MANUFACTURING LITHIUM METAL BATTERY SAMSUNG SDI CO., LTD. (KR) 2025-07-02 — — EP disclosed
WO-2024043738-A1 LITHIUM METAL BATTERY AND METHOD FOR MANUFACTURING LITHIUM METAL BATTERY 삼성에스디아이주식회사 2024-02-29 — — WO disclosed
CN-117185965-A Preparation method of sulfonic acrylic acid salt compound surfactant 安徽金桐精细化学有限公司 2023-12-08 — — CN disclosed
EP-3328947-B1 PHOTO-CURABLE INK, INK CARTRIDGE, AND IMAGE FORMING METHOD CANON KK (JP) 2023-02-01 — — EP disclosed
CN-115490592-A Method for constructing 1, 4-diene drug molecular skeleton 南京工业大学 2022-12-20 — — CN disclosed
CN-115322100-A Delta, epsilon-alkenyl ketone compound and preparation method and application thereof 南京工业大学 2022-11-11 — — CN disclosed
CN-113200856-B Trifluoromethyl propylene compound and preparation method and application thereof 南京工业大学 2022-06-07 — — CN disclosed
CN-113200856-A Trifluoromethyl propylene compound and preparation method and application thereof 南京工业大学 2021-08-03 — — CN disclosed
US-10850531-B2 Photocurable ink, ink container, and image forming method CANON KABUSHIKI KAISHA (JP) 2020-12-01 — — US disclosed
US-10351719-B2 Photo-curable ink, ink cartridge, and image forming method CANON KABUSHIKI KAISHA (JP) 2019-07-16 — — US disclosed
EP-3438210-A1 PHOTOCURABLE INK, INK CONTAINING BODY AND IMAGE FORMING METHOD C/o Canon Kabushiki Kaisha (JP) 2019-02-06 — — EP disclosed
US-20190031902-A1 PHOTOCURABLE INK, INK CONTAINER, AND IMAGE FORMING METHOD CANON KABUSHIKI KAISHA (JP) 2019-01-31 — — US disclosed
US-20180208784-A1 PHOTO-CURABLE INK, INK CARTRIDGE, AND IMAGE FORMING METHOD CANON KABUSHIKI KAISHA (JP) 2018-07-26 — — US disclosed
EP-3328947-A1 PHOTO-CURABLE INK, INK CARTRIDGE, AND IMAGE FORMING METHOD Canon Kabushiki Kaisha (JP) 2018-06-06 — — EP disclosed
CN-104797412-B Including the pneumatic tire of rubber liner that bonded by fiber module and its manufacture method 米其林集团总公司 2017-03-08 — — CN disclosed
WO-2017026102-A1 PHOTO-CURABLE INK, INK CARTRIDGE, AND IMAGE FORMING METHOD CANON KABUSHIKI KAISHA (JP) 2017-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260031392-A1 LITHIUM METAL BATTERY AND METHOD FOR MANUFACTURING LITHIUM METAL BATTERY CACNA2D4, CACNA2D1, CACNA1F ACHE 875/4885LMNA 1434/4885HSD17B10 3072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback